粤港澳大湾区医疗协同发展方略

The Strategy of Guangdong-Hong Kong-Macao Greater Bay Area Medical Collaborative Development

近年来,粤港澳医疗合作不断加强,在具备扎实基础的同时也面临诸多挑战,应在医师执业范围、医疗机构准入、医疗药品、器械进口等方面加强医疗规则衔接,在产学研协同创新、医疗科技平台发展、医疗资源供给、医疗体制机制等方面建立大湾区医疗健康共同体,深港在推动跨境医疗服务与合作、先行先试国际前沿医疗技术、完善医学人才培养机制、健全医院评审认证标准体系等方面构建深港医疗协同发展先行的示范区,推动粤港澳医疗协同发展。

In recent years,the medical cooperation among cities in the Guangdong-Hong Kong-Macao Greater Bay Area has been continuously strengthened. While it has a solid foundation, it also faces many challenges. It is necessary to strengthen the convergence of medical rules in the areas of physician practice, medical institution access, medical drugs, and equipment import. The development of medical technology platforms, the provision of medical resources, the medical system mechanism and other aspects have established a Greater Bay Area medical and health community. Shenzhen and Hong Kong are promoting cross-border medical services and cooperation, testing international cutting-edge medical technologies first, improving medical personnel training mechanisms, and enhancing the hospital evaluation and certification standard system and other aspects will establish a pilot area for the coordinated development of Shenzhen-Hong Kong healthcare, and promote the coordinated development of Guangdong-Hong Kong-Macao healthcare.